BlackRock, Inc. 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 12:21 pm Sale | 2024-03-31 | 13G | scPharmaceuticals Inc. SCPH | BlackRock Inc. BLK | 1,801,610 4.990% | -61,829 (-3.32%) | Filing |
| 2024-02-02 3:57 pm Purchase | 2023-12-31 | 13G | scPharmaceuticals Inc. SCPH | BlackRock Inc. BLK | 1,863,439 5.200% | 1,863,439 (New Position) | Filing |